Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | PAM | P19021 | 2/20 | 0.40 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 5/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12597463 | 0.82 | PAOX (0.41) | ALDH1A1ALOX15TSHRUSP2 | |
| SCHEMBL22889452 | 0.80 | ALDH1A1 (0.49) | DGKACYP1A2GAAALDH1A1ALOX15 | |
| SCHEMBL17450345 | 0.80 | ALDH1A1 (0.54) | DGKACYP1A2GAAALDH1A1ALOX15 | |
| SCHEMBL1533557 | 0.80 | ALDH1A1 (0.54) | DGKACYP1A2GAAALDH1A1ALOX15 | |
| SCHEMBL8421725 | 0.80 | SMN1; SMN2 (0.36) | CYP1A2GAAALDH1A1ALOX15TDP1 | |
| SCHEMBL4381355 | 0.80 | ALDH1A1 (0.48) | ALDH1A1ALOX15TDP1TSHRHSD17B10 | |
| SCHEMBL15619097 | 0.78 | ALDH1A1 (0.45) | ALDH1A1ALOX15TDP1TSHRHSD17B10 | |
| SCHEMBL14779178 | 0.77 | CA2 (0.46) | ALDH1A1ALOX15TSHRUSP2EPHX2 | |
| SCHEMBL2735589 | 0.77 | CA2 (0.46) | ALDH1A1ALOX15TSHRUSP2EPHX2 | |
| SCHEMBL4952312 | 0.77 | CA2 (0.46) | ALDH1A1ALOX15TSHRUSP2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150080538-A1 | Polyoxazolines with Inert Terminating Groups, Polyoxazolines Prepared from Protected Initiating Groups and Related Compounds | SERINA THERAPEUTICS (AL), INC. | 2015-03-19 | — | — | US | disclosed |
| US-8716491-B2 | Benzimidazolium dyes and their use as fluorescent chemosensors | NEW YORK UNIVERSITY (US) | 2014-05-06 | — | — | US | disclosed |
| US-20110123453-A1 | Polyoxazolines with Inert Terminating Groups, Polyoxazolines Prepared from Protected Initiating Groups and Related Compounds | SERINA THERAPEUTICS, INC. (US) | 2011-05-26 | — | — | US | disclosed |
| WO-2010006282-A2 | POLYOXAZOLINES WITH INERT TERMINATING GROUPS, POLYOXAZOLINES PREPARED FROM PROTECTED INITIATING GROUPS AND RELATED COMPOUNDS | SERINA THERAPEUTICS, INC. (US) | 2010-01-14 | — | — | WO | disclosed |
| US-20080160521-A1 | BENZIMIDAZOLIUM DYES AND THEIR USE AS FLUORESCENT CHEMOSENSORS | NEW YORK UNIVERSITY (US) | 2008-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110123453-A1 | Polyoxazolines with Inert Terminating Groups, Polyoxazolines Prepared from Protected Initiating Groups and Related Compounds | PHOSPHO1, PIP4K2B, PIP4K2C | DGKA 315/4885CYP1A2 1259/4885GAA 950/4885 |
| US-20080160521-A1 | BENZIMIDAZOLIUM DYES AND THEIR USE AS FLUORESCENT CHEMOSENSORS | IK, C9, CBR3 | DGKA 4657/4885CYP1A2 1915/4885GAA 3996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.